VTVTvTv Therapeutics Inc - Ordinary Shares - Class A
VTVT
vTv Therapeutics Inc - Ordinary Shares - Class A14,685
Mkt Cap
$144.16MVolume
35,148.0052W High
$44.0052W Low
$14.00PE Ratio
-38.43VTVT Fundamentals
Price
$35.76Prev Close
$35.50Open
$35.0550D MA
$35.71Beta
0.93Avg. Volume
63,410.25EPS (Annual)
-$3.20P/B
1.55Rev/Employee
$0.00$247.93
vTv Therapeutics (VTVT) is on the Move, Here's Why the Trend Could be Sustainable
If you are looking for stocks that are well positioned to maintain their recent uptrend, vTv Therapeutics (VTVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
vTv Therapeutics (NASDAQ:VTVT) Stock Price Passes Below Fifty Day Moving Average - What's Next?
vTv Therapeutics (NASDAQ:VTVT) Stock Crosses Below Fifty Day Moving Average - Here's What Happened...
vTv Therapeutics Inc. (NASDAQ:VTVT) Short Interest Update
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 112,740 shares, a...
vTv Therapeutics (NASDAQ:VTVT) Stock Passes Below Fifty Day Moving Average - Time to Sell?
vTv Therapeutics (NASDAQ:VTVT) Stock Price Crosses Below 50-Day Moving Average - Should You Sell...
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High?
The mean of analysts' price targets for vTv Therapeutics (VTVT) points to a 39.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Grows By 24.6%
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totaling 82,236 shares, a growth of 24.6% from the March 15th total of 65,987 shares. Based on an average daily...
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat reports. One...
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet
The mean of analysts' price targets for vTv Therapeutics (VTVT) points to a 31.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six brokerages that are currently covering the firm, MarketBeat Ratings...
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 39.9% in vTv Therapeutics (VTVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
<
1
2
...
>
Compact View
Not available
Not available